Article Information
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online January 1, 2006.
Copyright & Usage:
© 2006 Royal College of Physicians
Other Contributors:
- Chris P Day [FRCP FMedSci], Professor of Hepatology, University of Birmingham and Honorary Consultant, Queen Elizabeth Hospital, Birmingham
- Geoffrey Haydon [MRCP], Consultant Physican, Queen Elizabeth Hospital, Birmingham
Author Information
Article usage
Cited By...
Article Tools
Non-alcoholic fatty liver disease: current concepts and management strategies
Jump to section
Related Articles
Cited By...
- Relationship between non-alcoholic fatty liver disease during pregnancy and abnormal glucose metabolism during and after pregnancy
- Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial
- Resistance exercise improves autonomic regulation at rest and haemodynamic response to exercise in non-alcoholic fatty liver disease
- Tsc2, a positional candidate gene underlying a quantitative trait locus for hepatic steatosis
- Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
- Role of nuclear factor {kappa}B in liver health and disease
- Increased Risk of CKD among Type 2 Diabetics with Nonalcoholic Fatty Liver Disease
- Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance
- Fatty Liver: A Novel Component of the Metabolic Syndrome
- Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients: Response to Schindhelm, Heine, and Diamant
- Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Cardiovascular Events in Type 2 Diabetic Patients
- Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients